v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (41,329) $ (30,514)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 209 242
Stock-based compensation expense 5,870 6,598
Revaluation of contingent consideration 300 1,800
Changes in operating assets and liabilities:    
Accounts receivable, prepaid expenses and other assets (477) 7,155
Accounts payable 2,355 4,107
Accrued expenses and other liabilities (3,098) (10,643)
Deferred income (1,826) (1,795)
Net cash used in operating activities (37,996) (23,050)
Cash flows from investing activities:    
Purchases of property and equipment (71) (64)
Purchases of marketable securities (60,598) (29,926)
Proceeds from sales and maturities of marketable securities 40,000 54,989
Payments of deferred transaction consideration for in-licensed assets   (833)
Net cash (used in) provided by investing activities (20,669) 24,166
Cash flows from financing activities:    
Proceeds from issuance of common stock under the at-the-market sales agreement, net of issuance costs 57,880  
Payments of employee withholding taxes related to restricted stock unit award vesting (273) (284)
Proceeds from exercise of employee stock options and the issuance of stock 265  
Net cash provided by (used in) financing activities 57,872 (284)
Net (decrease) increase in cash and cash equivalents (793) 832
Cash and cash equivalents at beginning of period 19,960 24,570
Cash and cash equivalents at end of period 19,167 $ 25,402
Supplemental disclosure of non-cash investing activities:    
Additions to property and equipment included in accounts payable $ 3